Cargando…

Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action

BACKGROUND: We previously reported that pralidoxime facilitated restoration of spontaneous circulation by potentiating the pressor effect of epinephrine. We determined the optimal dose of pralidoxime during cardiopulmonary resuscitation and evaluated the involvement of α‐adrenoceptors in its pressor...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Yong Hun, Mamadjonov, Najmiddin, Lee, Hyoung Youn, Jeung, Kyung Woon, Lee, Byung Kook, Youn, Chun Song, Heo, Tag, Min, Yong Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335542/
https://www.ncbi.nlm.nih.gov/pubmed/32070203
http://dx.doi.org/10.1161/JAHA.119.015076
_version_ 1783554158842871808
author Jung, Yong Hun
Mamadjonov, Najmiddin
Lee, Hyoung Youn
Jeung, Kyung Woon
Lee, Byung Kook
Youn, Chun Song
Heo, Tag
Min, Yong Il
author_facet Jung, Yong Hun
Mamadjonov, Najmiddin
Lee, Hyoung Youn
Jeung, Kyung Woon
Lee, Byung Kook
Youn, Chun Song
Heo, Tag
Min, Yong Il
author_sort Jung, Yong Hun
collection PubMed
description BACKGROUND: We previously reported that pralidoxime facilitated restoration of spontaneous circulation by potentiating the pressor effect of epinephrine. We determined the optimal dose of pralidoxime during cardiopulmonary resuscitation and evaluated the involvement of α‐adrenoceptors in its pressor action. METHODS AND RESULTS: Forty‐four pigs randomly received 1 of 3 doses of pralidoxime (40, 80, or 120 mg/kg) or saline placebo during cardiopulmonary resuscitation, including epinephrine administration. Pralidoxime at 40 mg/kg produced the highest coronary perfusion pressure, whereas 120 mg/kg of pralidoxime produced the lowest coronary perfusion pressure. Restoration of spontaneous circulation was attained in 4 (36.4%), 11 (100%), 9 (81.8%), and 3 (27.3%) animals in the saline, 40, 80, and 120 mg/kg groups, respectively (P<0.001). In 49 rats, arterial pressure response to 40 mg/kg of pralidoxime was determined after saline, guanethidine, phenoxybenzamine, or phentolamine pretreatment, and the response to 200 mg/kg pf pralidoxime was determined after saline, propranolol, or phentolamine pretreatment. Pralidoxime at 40 mg/kg elicited a pressor response. Phenoxybenzamine completely inhibited the pressor response, but guanethidine and phentolamine did not. The pressor response of pralidoxime was even greater after guanethidine or phentolamine pretreatment. Pralidoxime at 200 mg/kg produced an initial vasodepressor response followed by a delayed pressor response. Unlike propranolol, phentolamine eliminated the initial vasodepressor response. CONCLUSIONS: Pralidoxime at 40 mg/kg administered with epinephrine improved restoration of spontaneous circulation rate by increasing coronary perfusion pressure in a pig model of cardiac arrest, whereas 120 mg/kg did not improve coronary perfusion pressure or restoration of spontaneous circulation rate. The pressor effect of pralidoxime was unrelated to α‐adrenoceptors and buffered by its vasodepressor action mediated by sympathoinhibition.
format Online
Article
Text
id pubmed-7335542
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73355422020-07-08 Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action Jung, Yong Hun Mamadjonov, Najmiddin Lee, Hyoung Youn Jeung, Kyung Woon Lee, Byung Kook Youn, Chun Song Heo, Tag Min, Yong Il J Am Heart Assoc Original Research BACKGROUND: We previously reported that pralidoxime facilitated restoration of spontaneous circulation by potentiating the pressor effect of epinephrine. We determined the optimal dose of pralidoxime during cardiopulmonary resuscitation and evaluated the involvement of α‐adrenoceptors in its pressor action. METHODS AND RESULTS: Forty‐four pigs randomly received 1 of 3 doses of pralidoxime (40, 80, or 120 mg/kg) or saline placebo during cardiopulmonary resuscitation, including epinephrine administration. Pralidoxime at 40 mg/kg produced the highest coronary perfusion pressure, whereas 120 mg/kg of pralidoxime produced the lowest coronary perfusion pressure. Restoration of spontaneous circulation was attained in 4 (36.4%), 11 (100%), 9 (81.8%), and 3 (27.3%) animals in the saline, 40, 80, and 120 mg/kg groups, respectively (P<0.001). In 49 rats, arterial pressure response to 40 mg/kg of pralidoxime was determined after saline, guanethidine, phenoxybenzamine, or phentolamine pretreatment, and the response to 200 mg/kg pf pralidoxime was determined after saline, propranolol, or phentolamine pretreatment. Pralidoxime at 40 mg/kg elicited a pressor response. Phenoxybenzamine completely inhibited the pressor response, but guanethidine and phentolamine did not. The pressor response of pralidoxime was even greater after guanethidine or phentolamine pretreatment. Pralidoxime at 200 mg/kg produced an initial vasodepressor response followed by a delayed pressor response. Unlike propranolol, phentolamine eliminated the initial vasodepressor response. CONCLUSIONS: Pralidoxime at 40 mg/kg administered with epinephrine improved restoration of spontaneous circulation rate by increasing coronary perfusion pressure in a pig model of cardiac arrest, whereas 120 mg/kg did not improve coronary perfusion pressure or restoration of spontaneous circulation rate. The pressor effect of pralidoxime was unrelated to α‐adrenoceptors and buffered by its vasodepressor action mediated by sympathoinhibition. John Wiley and Sons Inc. 2020-02-19 /pmc/articles/PMC7335542/ /pubmed/32070203 http://dx.doi.org/10.1161/JAHA.119.015076 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Jung, Yong Hun
Mamadjonov, Najmiddin
Lee, Hyoung Youn
Jeung, Kyung Woon
Lee, Byung Kook
Youn, Chun Song
Heo, Tag
Min, Yong Il
Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action
title Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action
title_full Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action
title_fullStr Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action
title_full_unstemmed Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action
title_short Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α‐Adrenergic Receptors in Its Pressor Action
title_sort effects of different doses of pralidoxime administered during cardiopulmonary resuscitation and the role of α‐adrenergic receptors in its pressor action
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335542/
https://www.ncbi.nlm.nih.gov/pubmed/32070203
http://dx.doi.org/10.1161/JAHA.119.015076
work_keys_str_mv AT jungyonghun effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction
AT mamadjonovnajmiddin effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction
AT leehyoungyoun effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction
AT jeungkyungwoon effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction
AT leebyungkook effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction
AT younchunsong effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction
AT heotag effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction
AT minyongil effectsofdifferentdosesofpralidoximeadministeredduringcardiopulmonaryresuscitationandtheroleofaadrenergicreceptorsinitspressoraction